Royal Prima PT

PRIM · JK · Healthcare / Medical Care Facilities

127.00IDR+2.00 (+1.60%)

Price History

Full chart

Market Stats

Previous Close125.00

Open127.00

Day Range123.00 – 127.00

52-Week Range64.00 – 134.00

Volume851.10K

Market Cap435.80B

P/E (TTM)0.00

Forward P/E0.00

EPS-5.82

Dividend Yield0.00%

Beta0.34

50-Day Avg116.10

200-Day Avg90.52

About

PT Royal Prima Tbk engages in providing hospital services and drugs in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. The company also provides health services, such as inpatient and outpatient medical services, including specialist and sub-specialist care. In addition, the company offers orthopaedic, eye, neurology, internal medicine, obstetrics and gynaecology, heart, lung, Ent-kl, urology. Further, it provides other services, including general surgery, surgical oncology, plastic surgery, pediatric surgery, neurosurgery, digestive surgery, dermatologist and venereologist, psychiatric, dental polyclinic, oral surgery, vascular surgery, kidney and hypertension, endocrine metabolic diabetes. The company was founded in 2013 and is based in Jakarta, Indonesia.

Company Details

SectorHealthcare
IndustryMedical Care Facilities
CEODr. Tommy Leonard
Employees797
HeadquartersGedung Grand Slipi Tower, Jakarta, Indonesia, 11480, Indonesia
Websitehttps://www.royalprima.com

Leadership

Dr. Tommy LeonardPresident Director · b. 1986
Engineer Siu Pen MokFinance & Administration Director and Director · b. 1965
Kalung Chandra S.E.Head of Internal Audit Unit
Ms. Maya TiraniCorporate Secretary · b. 1984

Financials

Income Statement

Currency: IDR	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	16.65B	72.74B	137.92B	177.60B	204.79B	174.22B	260.59B	599.96B	261.93B	265.34B	299.36B	338.91B
Growth (%)	-	+336.79%	+89.62%	+28.77%	+15.32%	-14.93%	+49.58%	+130.23%	-56.34%	+1.30%	+12.82%	+13.21%
Cost of Revenue	12.01B	59.79B	107.77B	129.52B	138.01B	129.67B	167.95B	420.86B	165.67B	190.10B	225.15B	270.69B
Gross Profit	4.64B	12.95B	30.15B	48.08B	66.78B	44.55B	92.64B	179.10B	96.27B	75.24B	74.20B	68.22B
Gross Margin	27.85%	17.81%	21.86%	27.07%	32.61%	25.57%	35.55%	29.85%	36.75%	28.36%	24.79%	20.13%
Operating Expense	8.02B	10.46B	14.92B	21.67B	44.57B	37.50B	42.64B	83.02B	71.53B	79.91B	95.52B	91.13B
Operating Income	-3.38B	2.49B	15.23B	26.41B	22.21B	7.05B	50.00B	96.08B	24.74B	-4.68B	-21.32B	-22.91B
Operating Margin	-20.29%	3.42%	11.04%	14.87%	10.84%	4.05%	19.19%	16.01%	9.44%	-1.76%	-7.12%	-6.76%
EBITDA	-3.38B	2.65B	15.88B	29.50B	38.80B	29.50B	74.47B	140.64B	67.04B	52.41B	-17.09B	40.62B
EBITDA Margin	-20.28%	3.64%	11.51%	16.61%	18.95%	16.93%	28.58%	23.44%	25.60%	19.75%	-5.71%	11.98%
Net Income	-2.30B	1.83B	11.54B	20.20B	17.21B	2.40B	38.17B	75.43B	21.59B	-2.75B	-18.41B	-21.82B
Net Income Margin	-13.84%	2.51%	8.37%	11.37%	8.40%	1.38%	14.65%	12.57%	8.24%	-1.04%	-6.15%	-6.44%
Interest Expense	0	0	42.08M	93.25M	83.13M	866.98M	357.99M	3.23M	95.30M	55.51M	47.05M	43.43M
Interest Expense % of Total Revenue	0.00%	0.00%	0.03%	0.05%	0.04%	0.50%	0.14%	0.00%	0.04%	0.02%	0.02%	0.01%

Balance Sheet

Currency: IDR	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	11.81B	27.11B	38.26B	309.64B	912.30B	911.55B	950.30B	1.13T	1.03T	1.03T	1.08T	1.05T
Total Liabilities	13.92B	26.38B	26.13B	59.22B	63.43B	60.38B	60.95B	167.11B	51.86B	49.69B	122.17B	106.64B
Total Equity	-2.10B	726.27M	12.13B	249.37B	847.71B	850.22B	888.48B	963.14B	981.62B	980.10B	961.39B	939.43B
Cash	655.36M	959.10M	1.19B	3.69B	3.18B	1.84B	41.86B	262.69B	64.40B	26.49B	20.72B	14.53B
Total Debt	-	-	1.25B	5.46B	-	10.25B	2.51B	5.18M	-	-	-	-
Net Debt	-655.36M	-959.10M	54.22M	1.77B	-3.18B	8.40B	-39.35B	-262.68B	-64.40B	-26.49B	-20.72B	-14.53B

Cash Flow

Currency: IDR	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	3.68B	-4.73B	28.02B	22.22B	35.33B	2.98B	60.16B	234.54B	21.59B	21.27B	46.98B	4.14B
Investing Cash Flow	-3.39M	-278.71M	-4.35B	-25.41B	-609.24B	-14.28B	-9.77B	-11.76B	-93.13B	-59.18B	-52.76B	-10.33B
Financing Cash Flow	-3.03B	5.33B	-23.39B	4.51B	574.57B	10.02B	-10.18B	-818.77M	-4.52B	0	0	-
Capital Expenditure	15.50M	300.42M	4.40B	25.41B	59.66B	14.34B	9.97B	13.05B	95.82B	61.24B	52.76B	10.95B
Free Cash Flow	3.66B	-5.03B	23.62B	-3.19B	-24.33B	-11.36B	50.20B	221.49B	-74.23B	-39.98B	-5.78B	-6.81B
FCF to OCF	99.58%	106.35%	84.31%	-14.38%	-68.85%	-380.76%	83.43%	94.44%	-343.82%	-187.97%	-12.30%	-164.63%

Earnings

Report Date	Jun 30, 2018	Sep 30, 2018	Dec 31, 2018	Mar 31, 2019	Jun 30, 2019	Sep 30, 2019	Dec 31, 2019	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.80	1.80	0.87	0.77	-0.06	-0.01	0.12	0.68	-0.00	4.55	6.03	4.67	13.94	12.47	-8.85	1.20	1.91	0.55	2.71	-2.07
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap435.80B

Enterprise Value390.44B

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.36

Price / Book0.44

EPS-5.82

Book Value277.39

Revenue (TTM)320.78B

Gross Profit (TTM)73.39B

EBITDA32.73B

Profit Margin-5.96%

Operating Margin1.63%

Return on Equity-2.02%

Return on Assets-1.27%

Shares Outstanding3.38B

Shares Float729.38M

Beta0.34

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%